Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does duloxetine safely and effectively reduce the severity of diabetic peripheral neuropathic pain?

Nature Clinical Practice Neurology volume 2, pages 18–19 (2006)Cite this article

boxed-textGoldstein DJ et al. (2005) Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain 116: 109–118

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Dyck PJ et al. (1993) The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology 43: 817–824

    Article  CAS  Google Scholar 

  2. Eastland RC (1995) Neuropathy in diabetes. In Diabetes in America, 339–348 (NIH Publication No. 95–1468). Washington DC: US Government Printing Office

    Google Scholar 

  3. Galer BS et al. (2000) Painful diabetic polyneuropathy: epidemiology, pain description, and quality of life. Diabetes Res Clin Pract 47: 123–128

    Article  CAS  Google Scholar 

  4. Bymaster FP et al. (2001) Comparative affinity of duloxetine and venlafaxine for serotonin and norepinephrine transporters in vitro and in vivo, human serotonin receptor subtypes, and other neuronal receptors. Neuropsychopharmacology 25: 871–880

    Article  CAS  Google Scholar 

  5. Freynhagen R et al. (2005) Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomized, double-blind, multicentre, placebo-controlled trial of flexible- and fixed-dose regimens. Pain 115: 254–263

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Christine Kyme, Assistant Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Associate Professor in the Department of Neurology at the University of Michigan and Associate Chief of Neurology at the VA Ann Arbor Healthcare System, MI, USA

    James W Russell

Authors
  1. James W Russell
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to James W Russell.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Russell, J. Does duloxetine safely and effectively reduce the severity of diabetic peripheral neuropathic pain?. Nat Rev Neurol 2, 18–19 (2006). https://doi.org/10.1038/ncpneuro0091

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpneuro0091

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing